This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Friday's Financial Winners & Losers

Financial stocks were blasting off Friday, together with the jubilant broad indices, in a last full-trading-day hurrah before the markets close on Christmas. Trading will end early on Monday.

Leading the skyward surge was First Marblehead (FMD - Get Report), which was up some 70% after Goldman Sachs (GS - Get Report) agreed to inject the student lender with up to $260.5 million by buying up to 19.99% of the firm's shares outstanding as of the time the deal closes. That kicks off today with a purchase of $59.8 million in securities convertible to shares at $11.24 apiece. Then, upon regulatory clearance, Goldman will buy up to another $200.7 million worth for a $15 per-share conversion price.

Goldman additionally agreed to establish a $1 billion warehouse lending facility for the company. Further, First Marblehead will suspend its dividend "for the foreseeable future" in an effort to preserve its cash levels. First Marblehead shares were jumping $7.65 to $18.89. Goldman was adding 3% at $208.79.

Merrill Lynch (MER) may also hop on the capital-infusion bandwagon: the troubled New York broker is currently in late-stage negotiations to get as much as $5 billion from Singapore-based Temasek Holdings, according to The Wall Street Journal. Shares gained 1.3% to $55.20.

And Marsh & McLennan (MMC - Get Report) was riding high after saying it will eject CEO Michael Cherkasky as soon as it finds a suitable replacement. The company board commented that MMC's financial performance this year "has fallen far short of our expectations," and that the management change "will best enable MMC to move forward and enhance shareholder value." Shares of the insurance broker were up 87 cents, or $3.5%, to $25.76.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ASFI $7.36 1.50%
FMD $3.96 3.40%
GS $147.23 -0.69%
MMC $55.51 0.42%
AAPL $94.27 -0.76%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs